Orsiro
Device Cardiology/Vascular Diseases
General payments
$7,677
Research payments
$1,529,231
Through program year 2020, $7,677 in general payments and $1,529,231 in research payments were reported against Orsiro (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $6,713 | 21 |
| 2020 | Research | $1,167,080 | 4,698 |
| 2019 | General | $964 | 6 |
| 2019 | Research | $362,152 | 1,557 |
Breakdown
The top 5 of 10 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 9 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
27 general · 6,255 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.